Literature DB >> 11312606

Sustained effects of gene-activated matrices after CNS injury.

M Berry1, A M Gonzalez, W Clarke, L Greenlees, L Barrett, W Tsang, L Seymour, J Bonadio, A Logan, A Baird.   

Abstract

We show that when gene-activated matrices (GAM) are placed between the proximal and distal stumps of severed rat optic nerves, DNA is retained within the GAM, promoting sustained transgene expression in the optic nerve, in the GAM itself, and, more importantly, in axotomized retinal ganglion cells (RGC). Plasmids that encode basic fibroblast growth factor (FGF2), brain-derived neurotrophic factor (BDNF), and neurotrophin-3 (NT3) promote sustained survival of RGC for over 3 months after the initial injury. These findings suggest that immobilized DNA implanted into a CNS lesion will be delivered by axon terminal uptake and retrograde transport to axotomized neurons. GAM may therefore be a useful agent for promoting sustained neuron survival and axon regeneration. Whether further optimization of the matrices, plasmids, promoters, and genes present in the GAM will promote even more survival or, alternatively, axon regeneration remains to be determined. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312606     DOI: 10.1006/mcne.2001.0975

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  20 in total

1.  Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection.

Authors:  Jae-Hyung Jang; Christopher B Rives; Lonnie D Shea
Journal:  Mol Ther       Date:  2005-09       Impact factor: 11.454

Review 2.  Matrices and scaffolds for DNA delivery in tissue engineering.

Authors:  Laura De Laporte; Lonnie D Shea
Journal:  Adv Drug Deliv Rev       Date:  2007-04-14       Impact factor: 15.470

3.  Plasmid releasing multiple channel bridges for transgene expression after spinal cord injury.

Authors:  Laura De Laporte; Yang Yang; Marina L Zelivyanskaya; Brian J Cummings; Aileen J Anderson; Lonnie D Shea
Journal:  Mol Ther       Date:  2008-12-02       Impact factor: 11.454

4.  Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels.

Authors:  Seungjin Shin; Lonnie D Shea
Journal:  Mol Ther       Date:  2010-01-05       Impact factor: 11.454

Review 5.  Engineering extracellular matrix through nanotechnology.

Authors:  Cassandra M Kelleher; Joseph P Vacanti
Journal:  J R Soc Interface       Date:  2010-09-22       Impact factor: 4.118

6.  Two and three-dimensional gene transfer from enzymatically degradable hydrogel scaffolds.

Authors:  Yuguo Lei; Quinn K T Ng; Tatiana Segura
Journal:  Microsc Res Tech       Date:  2010-09       Impact factor: 2.769

7.  Immunomodulatory activity of a Chinese herbal drug Yi Shen Juan Bi in adjuvant arthritis.

Authors:  Pathirage Kamal Perera; Yunman Li; Cheng Peng; Weirong Fang; Caifeng Han
Journal:  Indian J Pharmacol       Date:  2010-04       Impact factor: 1.200

8.  The noninvasive, quantitative, in vivo assessment of adenoviral-mediated gene delivery in skin wound biomaterials.

Authors:  Carrie Y Peterson; Ashkaun Shaterian; Alexandra K Borboa; Ana M Gonzalez; Bruce M Potenza; Raul Coimbra; Brian P Eliceiri; Andrew Baird
Journal:  Biomaterials       Date:  2009-09-24       Impact factor: 12.479

9.  DNA delivery from matrix metalloproteinase degradable poly(ethylene glycol) hydrogels to mouse cloned mesenchymal stem cells.

Authors:  Yuguo Lei; Tatiana Segura
Journal:  Biomaterials       Date:  2008-10-05       Impact factor: 12.479

10.  The deployment of adenovirus-containing gene activated matrices onto severed axons after central nervous system injury leads to transgene expression in target neuronal cell bodies.

Authors:  Ana Maria Gonzalez; Oscar Berlanga; Wendy E Leadbeater; Lisa Cooper-Charles; Karen Sims; Ann Logan; Brian Eliceiri; Martin Berry; Andrew Baird
Journal:  J Gene Med       Date:  2009-08       Impact factor: 4.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.